Upstream Bio, Inc. (UPB)
US$ 8.39-6.36%
Price Chart
Key Statistics
Market Cap
$ 407.33M
P/E Ratio
0.00
Revenue (TTM)
$ 2.21M
Volume
230.64K
52W High
$ 29.46
52W Low
$ 5.14
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
14.4559
200-Day MA
18.3712
52 Week High
29.46
52 Week Low
5.14
About UPB
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.
Employees
52
Headquarters
Waltham, MA
CEO
Dr. E. Rand Sutherland M.D., M.P.H., MPH
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg